COR Q3 2018 Earnings — Cencora, Inc. Revenue & Financial Results | Market Cap Arena

CORCencora, Inc.

$68B

Q3 2018 Earnings

Healthcare Medical - Distribution

Income Statement

Revenue

$43.1B+11.5% YoY

Gross Profit

$1.1B2.4% margin

Operating Income

$429M1.0% margin

Net Income

$276M0.6% margin

EPS (Diluted)

$1.25

QoQ Revenue Growth

+5.1%

Cash Flow

Operating Cash Flow

$823M

Free Cash Flow

$744M

Stock-Based Comp.

$9M

Balance Sheet

Total Assets

$38.3B

Total Liabilities

$35.0B

Stockholders' Equity

$3.1B

Cash & Equivalents

$2.4B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$43.1B	$38.7B	+11.5%
Gross Profit	$1.1B	$980M	+7.7%
Operating Income	$429M	$455M	-5.7%
Net Income	$276M	$50M	+447.8%

Revenue Segments

Pharmaceutical Distribution

$41.6B96%

Other Segments

$1.6B4%

Geographic Segments

Other Segments

$1.6B100%